Sumitomo Pharma revenue and financials
In the fiscal year ended March 2026, Sumitomo Pharma reported revenue of ¥453.29B (+13.66% year over year). Net income was ¥106.87B, a net margin of 23.6%.
Fiscal year ending in March. Sources and method on the page How we analyse stocks.
At a glance
- Revenue growth
- +13.66%
- FY to Mar 2026 vs FY to Mar 2025
- Net income growth
- +352.17%
- FY to Mar 2026 vs FY to Mar 2025
- Net margin
- 23.6%
- FY to Mar 2025: 5.9%
How Sumitomo Pharma is changing
Calculated from the annual statements; each fiscal year is labelled with the year it ends.
Revenue fell 2.6% a year on average over the last 5 years
Compound annual growth rate: from ¥515.95B in 2021 to ¥453.29B in 2026.
Operating margin rose from −22.7% to 11.6%
Operating income over revenue, 2023 → 2026: 34.4 percentage points.
Profitable in 3 of 5 fiscal years
Positive net income, fiscal years 2022–2026.
Financial data
Amounts in millions of JPY; per-share values in JPY; shares in millions.
| Item | FY to Mar 2026 | FY to Mar 2025 | FY to Mar 2024 | FY to Mar 2023 | FY to Mar 2022 | FY to Mar 2021 | FY to Mar 2020 | FY to Mar 2019 | FY to Mar 2018 | FY to Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 453,294 | 398,832 | 314,558 | 555,544 | 560,035 | 515,952 | 482,732 | 459,267 | 466,838 | 411,638 |
| Cost of revenue | 196,401 | 153,330 | 126,577 | 178,919 | 157,127 | 137,773 | 129,673 | 113,553 | 112,345 | 100,071 |
| Gross profit | 256,893 | 245,502 | 187,981 | 376,625 | 402,908 | 378,179 | 353,059 | 345,714 | 354,493 | 311,567 |
| Selling, general and administrative | 163,016 | 180,155 | 397,705 | 339,212 | 217,339 | 173,666 | 143,076 | 172,581 | 177,113 | 172,335 |
| Research and development | 43,996 | 49,865 | 112,637 | 131,858 | 94,903 | 132,682 | 115,112 | 102,364 | 86,928 | 80,819 |
| Operating income | 52,801 | 17,770 | -355,136 | -126,349 | 59,967 | 54,299 | 82,922 | 61,272 | 82,718 | 52,759 |
| EBIT | 52,801 | 17,770 | -355,136 | -126,349 | 59,967 | 54,299 | 82,922 | 61,272 | 82,718 | 52,759 |
| EBITDA | 71,929 | 41,044 | -317,371 | -85,086 | 98,315 | 76,972 | 100,287 | 75,248 | 95,605 | 71,376 |
| Interest expense | 5,365 | 4,580 | 3,893 | 2,640 | 2,970 | 2,436 | 699 | 178 | 394 | 631 |
| Pre-tax income | 100,344 | 17,611 | -323,114 | -47,920 | 82,961 | 77,851 | 83,947 | 65,046 | 84,866 | 47,217 |
| Income tax | -6,521 | -6,024 | -8,185 | 48,794 | 42,361 | 41,022 | 48,029 | 16,419 | 31,418 | 18,226 |
| Net income | 106,865 | 23,634 | -314,969 | -74,512 | 56,413 | 56,219 | 40,753 | 48,627 | 53,448 | 28,991 |
| Net income to common shareholders | 106,865 | 23,634 | -314,969 | -74,512 | 56,413 | 56,219 | 40,753 | 48,627 | 53,448 | 28,991 |
| Basic EPS | 268.99 | 59.49 | -792.79 | -187.55 | 141.99 | 141.50 | 102.58 | 122.39 | 134.53 | 72.97 |
| Diluted EPS | 268.99 | 59.49 | -792.79 | -187.55 | 141.99 | 141.50 | 102.58 | 122.39 | 134.53 | 72.97 |
| Average shares (basic) | 397 | 397 | 397 | 397 | 397 | 397 | 397 | 397 | 397 | 397 |
| Average shares (diluted) | 397 | 397 | 397 | 397 | 397 | 397 | 397 | 397 | 397 | 397 |
| Dividend per share | — | — | — | 21.00 | 28.00 | 28.00 | 28.00 | 26.00 | 18.00 | 18.00 |
Amounts in millions of JPY; per-share values in JPY; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 136,995 | 129,495 | 105,548 | 120,624 | 119,120 | 108,002 | 105,649 | 112,434 | 90,074 | 90,675 | 79,530 | 82,386 |
| Cost of revenue | 62,111 | 61,414 | 51,263 | 55,437 | 45,589 | 44,112 | 39,564 | 41,439 | 37,378 | 34,949 | 33,387 | 32,867 |
| Gross profit | 74,884 | 68,081 | 54,285 | 65,187 | 73,531 | 63,890 | 66,085 | 70,995 | 52,696 | 55,726 | 46,143 | 49,519 |
| Selling, general and administrative | 39,479 | 39,237 | 43,520 | 42,935 | 40,904 | 35,657 | 49,115 | 41,044 | 44,638 | 45,358 | 206,147 | 57,514 |
| Research and development | 12,326 | 11,430 | 16,122 | 10,350 | 9,349 | 8,175 | 13,126 | 10,467 | 13,148 | 13,124 | 38,990 | 23,291 |
| Operating income | 23,291 | 17,751 | -55,808 | 12,997 | 74,574 | 21,038 | 4,544 | 21,405 | -5,074 | -3,105 | -237,391 | -31,247 |
| EBIT | 23,291 | 17,751 | -55,808 | 12,997 | 74,574 | 21,038 | 4,544 | 21,405 | -5,074 | -3,105 | -237,391 | -31,247 |
| EBITDA | 28,169 | 22,650 | -52,479 | 18,315 | 79,852 | 26,241 | 8,063 | 27,471 | 1,708 | 3,802 | -227,886 | -21,646 |
| Interest expense | 3,001 | 2,093 | 460 | 5,138 | -4,459 | 9,053 | 15,428 | — | 44,535 | 2,025 | 13,608 | 1,083 |
| Pre-tax income | 21,087 | 18,295 | -1,195 | 8,737 | 80,870 | 11,932 | -6,415 | 56,432 | -49,609 | 17,203 | -217,923 | -49,064 |
| Income tax | -154 | 1,298 | -383 | -80.0 | -6,784 | 726 | -8,830 | 2,984 | -1,445 | 1,267 | -20,693 | 899 |
| Net income | 21,241 | 16,997 | -812 | 8,817 | 87,654 | 11,206 | 2,415 | 53,448 | -48,166 | 15,937 | -197,261 | -49,967 |
| Net income to common shareholders | 21,241 | 16,997 | -812 | 8,817 | 87,654 | 11,206 | 2,415 | 53,448 | -48,166 | 15,937 | -197,261 | -49,967 |
| Basic EPS | 47.34 | 39.02 | -2.04 | 22.19 | 220.63 | 28.21 | 6.08 | 134.53 | -121.24 | 40.11 | -496.52 | -125.77 |
| Diluted EPS | 47.34 | 39.02 | -2.04 | 22.19 | 220.63 | 28.21 | 6.08 | 134.53 | -121.24 | 40.11 | -496.52 | -125.77 |
| Average shares (basic) | 449 | 436 | 397 | 397 | 397 | 397 | 397 | 397 | 397 | 397 | 397 | 397 |
| Average shares (diluted) | 449 | 436 | 397 | 397 | 397 | 397 | 397 | 397 | 397 | 397 | 397 | 397 |
Amounts in millions of JPY; per-share values in JPY; shares in millions.
| Item | FY to Mar 2026 | FY to Mar 2025 | FY to Mar 2024 | FY to Mar 2023 | FY to Mar 2022 | FY to Mar 2021 | FY to Mar 2020 | FY to Mar 2019 | FY to Mar 2018 | FY to Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 804,571 | 742,604 | 907,506 | 1,134,742 | 1,308,007 | 1,308,127 | 1,252,878 | 834,717 | 809,684 | 793,950 |
| Current assets | 279,252 | 253,168 | 269,569 | 381,860 | 499,521 | 459,795 | 364,090 | 373,268 | 348,581 | 376,454 |
| Cash and equivalents | 44,310 | 36,288 | 29,047 | 143,478 | 202,984 | 193,698 | 101,708 | 137,296 | 147,775 | 71,408 |
| Short-term investments | 5,327 | 16,840 | 7,085 | 20,174 | — | — | — | — | — | 34,195 |
| Receivables | 134,687 | 84,282 | 97,239 | 98,630 | 151,500 | 136,060 | 140,368 | 119,243 | 113,401 | 127,659 |
| Inventory | 85,414 | 96,917 | 115,350 | 94,405 | 99,021 | 92,215 | 79,368 | 66,889 | 60,169 | 68,806 |
| Net property, plant and equipment | 44,231 | 46,648 | 57,895 | 58,909 | 64,091 | 64,966 | 65,748 | 59,485 | 58,204 | 59,253 |
| Goodwill | 211,098 | 197,406 | 199,783 | 209,415 | 195,144 | 176,492 | 169,046 | 99,348 | 95,097 | 90,565 |
| Other intangible assets | 160,474 | 172,509 | 195,652 | 329,314 | 398,692 | 383,406 | 421,791 | 171,390 | 189,681 | 213,745 |
| Long-term investments | 36,400 | 5,588 | 182,368 | 144,399 | 127,909 | 203,277 | 205,096 | 80,507 | 76,513 | 53,221 |
| Current liabilities | 271,500 | 240,603 | 515,474 | 370,888 | 278,373 | 278,147 | 496,498 | 198,174 | 210,248 | 228,447 |
| Accounts payable | 12,083 | 9,225 | 67,720 | 52,141 | 46,183 | 64,638 | 62,251 | 49,238 | 58,708 | 14,514 |
| Long-term debt | 179,056 | 258,982 | 133,367 | 244,128 | 243,963 | 263,859 | 25,020 | 27,980 | 30,940 | 10,000 |
| Total debt | 186,086 | 271,806 | 253,276 | 255,784 | 279,519 | 285,680 | 45,259 | 32,983 | 46,052 | 28,000 |
| Total liabilities | 512,104 | 573,125 | 751,370 | 727,960 | 634,438 | 659,949 | 620,773 | 336,579 | 356,961 | 333,294 |
| Total equity (incl. minority) | 292,467 | 169,479 | 156,136 | 406,782 | 673,569 | 648,178 | 632,105 | 498,138 | 452,723 | 460,656 |
| Retained earnings | 158,981 | 46,784 | -22,665 | 280,999 | 514,210 | 508,677 | 457,330 | 431,799 | 396,037 | 363,627 |
| Minority interest | — | 0.0 | 73.0 | 33.0 | 65,681 | 67,608 | 102,620 | — | — | — |
Amounts in millions of JPY; per-share values in JPY; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 851,053 | 844,883 | 804,571 | 815,521 | 778,404 | 733,333 | 742,604 | 852,115 | 799,765 | 868,932 | 907,506 | 1,059,970 |
| Current assets | 337,366 | 317,482 | 279,252 | 295,918 | 271,108 | 256,718 | 253,168 | 333,688 | 311,929 | 325,906 | 269,569 | 264,167 |
| Cash and equivalents | 77,759 | 76,640 | 44,310 | 57,323 | 38,490 | 20,453 | 36,288 | 85,393 | 99,082 | 78,399 | 29,047 | 36,457 |
| Short-term investments | — | 7,400 | 5,327 | 10,006 | — | 15,877 | 16,840 | — | — | — | — | — |
| Receivables | 152,291 | 142,785 | 134,687 | 135,660 | 127,263 | 86,131 | 84,282 | 97,259 | 68,886 | 90,488 | 97,239 | 97,306 |
| Inventory | 90,485 | 79,675 | 85,414 | 82,276 | 82,755 | 89,751 | 96,917 | 107,426 | 105,637 | 117,052 | 115,350 | 104,769 |
| Net property, plant and equipment | 44,295 | 44,511 | 44,231 | 44,600 | 44,939 | 46,103 | 46,648 | 52,613 | 57,368 | 59,654 | 57,895 | 59,019 |
| Goodwill | 207,678 | 214,385 | 211,098 | 206,649 | 196,457 | 191,175 | 197,406 | 208,787 | 188,549 | 212,589 | 199,783 | 222,415 |
| Other intangible assets | 154,039 | 157,358 | 160,474 | 163,531 | 166,510 | 164,726 | 172,509 | 194,484 | 179,992 | 205,793 | 195,652 | 332,372 |
| Long-term investments | 39,397 | 38,818 | 36,400 | 34,866 | 98,926 | 7,346 | 5,588 | — | 59,357 | — | 182,368 | 173,195 |
| Current liabilities | 247,924 | 261,873 | 271,500 | 211,781 | 199,029 | 231,687 | 240,603 | 499,339 | 484,177 | 498,441 | 515,474 | 421,155 |
| Accounts payable | 61,778 | 48,864 | 12,083 | 35,108 | 42,046 | 39,308 | 9,225 | 49,278 | 58,581 | 58,259 | 67,720 | 50,385 |
| Long-term debt | 119,692 | 119,658 | 179,056 | 258,954 | 258,850 | 259,057 | 258,982 | 119,463 | 133,430 | 133,398 | 133,367 | 184,254 |
| Total debt | — | 160,658 | 186,086 | 258,954 | 258,850 | 309,245 | 271,806 | 374,423 | 133,430 | 390,072 | 253,276 | — |
| Total liabilities | 419,948 | 436,328 | 512,104 | 526,582 | 512,816 | 557,100 | 573,125 | 686,000 | 685,521 | 708,003 | 751,370 | 716,377 |
| Total equity (incl. minority) | 431,105 | 408,555 | 292,467 | 288,939 | 265,588 | 176,233 | 169,479 | 166,115 | 114,244 | 160,929 | 156,136 | 343,593 |
| Retained earnings | 200,284 | 176,508 | 158,981 | 156,389 | 147,516 | 57,924 | 46,784 | 41,601 | -13,254 | 35,298 | -22,665 | 171,708 |
| Minority interest | — | — | — | — | — | — | 0.0 | — | 74.0 | 72.0 | 73.0 | 42.0 |
Amounts in millions of JPY; per-share values in JPY; shares in millions.
| Item | FY to Mar 2026 | FY to Mar 2025 | FY to Mar 2024 | FY to Mar 2023 | FY to Mar 2022 | FY to Mar 2021 | FY to Mar 2020 | FY to Mar 2019 | FY to Mar 2018 | FY to Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 71,715 | 16,500 | -241,893 | 11,937 | 31,239 | 135,601 | 46,128 | 48,711 | 93,420 | 21,624 |
| Depreciation and amortization | 19,128 | 23,274 | 37,765 | 41,263 | 38,348 | 22,673 | 17,365 | 13,976 | 12,887 | 18,617 |
| Capital expenditure | -4,609 | -8,498 | -10,771 | -8,467 | -7,347 | -6,048 | -7,722 | -9,265 | -5,129 | -8,132 |
| Investing cash flow | 22,549 | 99,754 | 33,036 | 52,419 | -18,278 | 8,875 | -312,684 | -35,049 | -16,523 | -59,729 |
| Financing cash flow | -91,266 | -108,836 | 77,851 | -146,817 | -21,426 | -57,215 | 231,081 | -28,645 | -29,610 | 9,881 |
| Dividends paid | -2.0 | -3.0 | -2,792 | -11,125 | -11,126 | -11,120 | -13,106 | -11,122 | -7,944 | -7,151 |
| Debt issued | — | 146,187 | 84,000 | 85,559 | 29.0 | 243,927 | 270,000 | — | 35,300 | 39,036 |
| Debt repaid | -90,940 | -255,586 | 0.0 | -20,060 | -4,960 | -267,960 | -19,623 | -16,460 | -55,900 | -22,000 |
| Effect of exchange rates | 5,024 | -177 | 15,440 | 24,090 | 17,751 | 4,729 | -113 | 4,504 | -5,115 | -1,748 |
| Net change in cash | 8,022 | -5,931 | -114,431 | -59,506 | 9,286 | 91,990 | -35,588 | -10,479 | 42,172 | -29,971 |
| Free cash flow | 67,106 | 8,002 | -252,664 | 3,470 | 23,892 | — | — | — | — | — |
| Levered free cash flow | 65,707 | 5,270 | -253,962 | 45,988 | 15,575 | 85,101 | 52,268 | 5,471 | 144,670 | 66,245 |
Amounts in millions of JPY; per-share values in JPY; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 24,116 | -7,443 | 29,447 | 24,243 | 18,217 | -192 | 11,009 | 939 | 29,605 | -25,053 | -11,161 | -56,235 |
| Depreciation and amortization | 4,878 | 4,899 | 3,329 | 5,318 | 5,278 | 5,203 | 3,519 | 6,066 | 6,782 | 6,907 | 9,505 | 9,601 |
| Capital expenditure | -77.0 | -663 | -799 | -1,287 | -1,049 | -1,474 | -2,375 | -2,057 | -1,763 | -2,303 | -4,280 | -2,235 |
| Investing cash flow | 486 | 49.0 | -1,824 | -3,261 | 31,948 | -4,314 | 2,311 | -8.0 | -4,670 | 102,121 | -5,306 | 5,667 |
| Financing cash flow | -21,572 | 39,152 | -42,600 | -4,697 | -47,188 | 3,219 | -63,535 | -15,865 | -192 | -29,244 | 5,736 | 27,318 |
| Dividends paid | — | -1.0 | 0.0 | -1.0 | 0.0 | -1.0 | -1.0 | -1.0 | 0.0 | -1.0 | -1.0 | -6.0 |
| Debt issued | -2,870 | 2,870 | — | — | -3,970 | 3,970 | 146,187 | — | — | — | 7,000 | 28,000 |
| Debt repaid | -18,576 | -60,505 | -42,499 | -4,607 | -41,860 | -670 | -209,831 | -16,002 | 991 | -29,403 | — | — |
| Effect of exchange rates | -1,911 | 572 | 1,964 | 2,548 | 1,300 | -788 | 1,110 | 117 | -2,932 | 1,528 | 3,321 | -690 |
| Net change in cash | 1,119 | 32,330 | -13,013 | 18,833 | 4,277 | -2,075 | -62,277 | -13,689 | 20,683 | 49,352 | -7,410 | -23,940 |
| Free cash flow | 24,039 | -8,106 | 28,648 | 22,956 | 17,168 | -1,666 | 8,634 | -1,118 | 27,842 | -27,356 | -15,441 | -58,470 |
| Levered free cash flow | 5,470 | -2,824 | -8,019 | 19,157 | 67,505 | -8,634 | -25,285 | -4,827 | -7,712 | 4,873 | -132,411 | -46,010 |
Financial statements of similar companies
Companies in the group: same industry, similar size
